Net selling: insiders sold $12.4M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsEach bar is 100% of that source’s money. The notch marks an even split.
Lean is the direction of the latest moves. Descriptive, not advice.
Buys/Adds (2)
Menlo Advisors
$5.4M
bought
Bank of America
$12.0M
added
Sells/Trims (1)
Gotham Asset
$11.7M
trimmed
Buys (1)
Halbert Jon
$990K
bought
Sells (2)
Denton John Russel
$239K
sold
Brille Brian J
$12.1M
sold
No tracked top-trader positions in CAI as of Oct 24, 10:57 UTC.
Hyperliquid positioning - not every stock is covered
Last report
Aug 5, 2026
Period ending
Jun 30, 2026
Earnings per share
$0.01 expected
Revenue
Financial statements: Alpha Vantage
Estimates as of Oct 23, 2026
EPS expected
-$0.01 to $0.07
Revenue expected
13 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 5, 2026 | $0.00 / $0.01Yahoo Finance | -$0.01 miss | $263.7M No estimate | Unavailable |
| Mar 31, 2026 | May 7, 2026 | $0.00 / -$0.02Yahoo Finance | +$0.02 beat | $216.2M No estimate | Unavailable |
| Dec 31, 2025 | Feb 26, 2026 | $0.28 / $0.10Yahoo Finance | +$0.18 beat | $292.9M No estimate | Unavailable |
| Sep 30, 2025 | Nov 5, 2025 | $0.08 / -$0.14Yahoo Finance | +$0.22 beat | $216.8M No estimate | Unavailable |
| Jun 30, 2025 | Aug 12, 2025 | -$1.11 / -$0.22Alpha Vantage | -$0.89 miss | $181.4M No estimate | Unavailable |
| Mar 31, 2025 | May 28, 2025 | Unavailable | - | $120.9M No estimate | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $216.8M | $292.9M | $216.2M | $263.7M |
| Cost of what it sold | $69.3M | $72.0M | $74.8M | $84.1M |
| Gross profit | $147.5M | $220.9M | $141.3M | $179.6M |
| What it spent | ||||
| Research and development | $21.6M | $31.8M | $5.4M | $32.4M |
| Sales and admin | $52.0M | $56.5M | $59.7M | $66.5M |
| Other operating costs | $41.3M | $44.2M | $71.0M | $53.8M |
| Total operating expenses | $114.9M | $132.5M | $136.1M | $152.7M |
| What was left | ||||
| Operating profit | $32.6M | $88.4M | $5.3M | $26.9M |
| Interest on debt | $13.5M | $11.4M | $12.8M | $9.2M |
| Profit before tax | $24.3M | $82.0M | -$644.0K | -$614.0K |
| Tax | — | — | -$134.0K | $23.0K |
| Net profit | $24.3M | $82.0M | -$510.0K | -$637.0K |
| EBITDA | $42.7M | $97.6M | $17.2M | $15.2M |
This stock is in a strong uptrend.
Trend
Strong uptrend
80 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
Caris Life Sciences, Inc. (NASDAQ:CAI) Stock Has Average Target Price of $27.82 According to Brokerages
Leans bullishOct 18Caris Life Sciences Inc. (CAI) Stock Price | Live Quotes & Charts | NASDAQ
Leans bullishOct 13Caris Life Sciences (NASDAQ:CAI) Shares Up 7.6% - Still a Buy?
NeutralOct 10Caris Life Sciences, Inc. $CAI Shares Sold by Zevenbergen Capital Investments LLC
NeutralOct 9